Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility

Human Reproduction

Volumn 16, Issue 12, 2001, Pages 2587-2592

  Omland, A K ^a   Fedorcsak P ^a   Storeng, R ^a   Dale, P O ^a   Abyholm T ^a   Tanbo, T ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Endometriosis; IVF; Natural cycle; Tubal factor; Unexplained infertility

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; ASPIRATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONE DETERMINATION; HUMAN; INFERTILITY; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALE; MONITORING; OOCYTE; OUTCOMES RESEARCH; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PERITONEAL DISEASE; PREGNANCY; PROSPECTIVE STUDY; UTERINE TUBE;

FALLOPIA;

EID: 0035657070     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.12.2587     Document Type: Article

References (43)

1. The first attempt at IVF treatment. Results and requirements for a satisfactory success rate
2. In vivo fertilization procedures in infertile women with patent Fallopian tubes: A comparison of gamete intra-Fallopian transfer, combined intrauterine and intraperitoneal insemination, and controlled ovarian hyperstimulation alone
3. Revised American Fertility Society classification of endometriosis
4. The effect of endometriosis on implantation: Results from the Yale University in vitro fertilization and embryo transfer program
5. Endometriosis 1991: A discussion document
6. Outcome of IVF in patients with endometriosis in comparison with tubal-factor infertility
7. Is mild endometriosis a progressive disease?
8. Pituitary-ovarian dysfunction as a cause for endometriosis-associated and unexplained infertility
9. Fertilization failure and dysfunctions as possible causes for human idiopathic infertility
10. New clinical guidelines are needed for the treatment of endometriosis
11. Natural cycle in-vitro fertilization: Cost-effectiveness analysis and factors influencing outcome
12. The role of cell-mediated immunity in pathogenesis of endometriosis
13. The effect of endometriosis, its stage and activity, and autoantibodies on in vitro fertilization and embryo transfer success rates
14. The impact of ovarian hyperstimulation on implantation and fetal development in mice
15. Treatment with gonadotropins impaires implantation and fetal development in mice
16. Endometriosis does not exist; All women have endometriosis
17. The defense against endometriosis
18. Endometriosis: The enigma persists. Highlights from the 7th World Congress of Endometriosis
19. Effect of cause of infertility on success during IVF
20. Is the endometrium or oocyte/embryo affected in endometriosis?
21. Results of IVF in patients with endometriosis: The severity of the disease does not affect the outcome, or the incidence of miscarriage
22. Potential biochemical markers of uterine receptivity
23. Correlation of ultrasonic and endocrinologic assessment of human follicular development
24. Reduced preovulatory granulosa cell steroidogenesis in women with endometriosis
25. The contribution of subtle oocyte or sperm dysfunction affecting fertilization in endometriosis-associated or unexplained infertility: A controlled comparison with tubal infertility and use of donor spermatozoa
26. The impact of endometriosis on the reproductive outcome of infertile patients
27. Is mild endometriosis a condition occurring intermittently in all women?
28. Intensive hormone monitoring in women with unexplained infertility: Evidence for subtle abnormalities suggestive of diminished ovarian reserve
29. A prospective controlled study of in-vitro fertilization, gamete intra-Fallopian transfer and intrauterine insemination combined with superovulation
30. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles
31. Pinopodes as markers of endometrial receptivity in clinical practice
32. Artificial insemination by husband in unexplained infertility compared with infertility associated with peritoneal endometriosis
33. Embryo implantation after human in vitro fertilization: Importance of endometrial receptivity
34. The follicular and endocrine environment in women with endometriosis: Local and systemic cytokine production
35. Revival of natural cycle in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): A pilot study with minimal stimulation
36. Endometriosis and infertility: New concepts
37. Outcome of patients with endometriosis in assisted reproduction; Results from in-vitro fertilization and oocyte donation
38. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients
39. In vitro fertilization/embryo transfer in unexplained infertility and minimal peritoneal endometriosis
40. Ovarian stimulation and ovarian tumours: A critical reappraisal
41. Hormonal profiles and embryo quality in women with severe endometriosis treated by in vitro fertilization and embryo transfer
42. Empty follicle syndrome: Evidence for recurrence